생명과학회지 (Journal of Life Science)

  • 제16권6호
  • /
  • Pages.964-971
  • /
  • 2006
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

Disulfiram에 의한 type IV collagenase 저해효과

Inhibitory Effects of Type IV Collagenase by Disulfiram

  • 신두일 (대구가톨릭대학교 의과대학 병리학교실) ;
  • 박재복 (대구가톨릭대학교 의과대학 병리학교실) ;
  • 박관규 (대구가톨릭대학교 의과대학 병리학교실) ;
  • 조창호 (대구가톨릭대학교 의과대학 병리학교실) ;
  • 오훈규 (대구가톨릭대학교 의과대학 병리학교실) ;
  • 최창혁 (대구가톨릭대학교 의과대학 정형외과학교실) ;
  • 조현지 (대구가톨릭대학교 의과대학 병리학교실) ;
  • 장영채 (대구가톨릭대학교 의과대학 병리학교실)
  • Sin, Doo-Il (Department of Pathology, Catholic University of Daegu School of Medicine) ;
  • Park, Jae-Bok (Department of Pathology, Catholic University of Daegu School of Medicine) ;
  • Park, Kwan-Kyu (Department of Pathology, Catholic University of Daegu School of Medicine) ;
  • Cho, Chang-Ho (Department of Pathology, Catholic University of Daegu School of Medicine) ;
  • Oh, Hoon-Kyu (Department of Pathology, Catholic University of Daegu School of Medicine) ;
  • Choi, Chang-Hyuk (Department of Orthopedic Surgery, Catholic University of Daegu School of Medicine) ;
  • Cho, Hyun-Ji (Department of Pathology, Catholic University of Daegu School of Medicine) ;
  • Chang, Young-Chae (Department of Pathology, Catholic University of Daegu School of Medicine)
  • 발행 : 2006.10.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

기질의 침윤과 전이를 특징으로 하는 악성종양 세포는 세포외 기질이나 기저막에 의존적으로 작용한다. 세포외 기질을 분해하는 효소인 matrix metalloproteinase (MMP) 계들의 발현 및 활성증가는 대부분의 악성종양세포에서 전이와 침윤을 촉진시킨다. MMP family 가운데 특히 type IV collagenase 활성을 지닌 MMP-2와 MMP-9은 세포외기질의 중요한 구성분인 collagen, fibronectin을 분해하는 특성을 가지며 암 전이를 용이하게 하는 주요한 효소로 잘 알려져 있다. 본 연구에서는 항암후보물질인 disulfiram이 골 육종 (U20S), 신장암 (Caki-1) 및 자궁암 (Caski) 세포에서 MMP-2와 MMP-9의 효소활성 및 발현억제에 대해 조사하였다. MTT assay를 이용하여 disulfiram에 대한 암세포 viability 실험에서는 disulfiram이 암세포의 viability를 저해하였다. 또한 zymography, western blot 및 RT-PCR 등을 이용한 type IV collagenase의 활성 및 발현 실험에서 disulfiram은 type IV collagenase의 활성을 비롯하여 단백질 및 mRNA 발현을 억제시키는 것을 확인하였다. 따라서 disulfiram이 MMP-2와 MMP-9의 활성 및 발현 억제 기전을 통하여 골 육종, 신장암 및 자궁경부암 세포의 작용을 억제한다는 연구 결과는 disulfiram이 각종 악성종양의 침윤과 전이를 억제 또는 방지하기 위한 치료물질로서 임상에서 활용할 수 있는 가능성을 보여준다.

The cancer cells, characterized by local invasion and distant metastasis, are very dependant on extracellular matrix. The expression of matrix metalloproteinases (MMPs) has been implicated in the invasion and metastasis of cancer cells. Among the human MMPs, matirx metalloproteinase-2 (MMP-2) and matrix metalloproteinse-9 (MMP-9) are key enzymes that degrade type IV collagen of the matrix. Here, we studied the effect of disulfiram, an anti-tumor compound, on the suppression of the tumor invasion and the activity of MMP-2, MMP-9 in human osteosarcoma cells (U2OS). Disulfiram had the type IV collagenase inhibitory activity, the effect of inhibition of gene and protein expression, and these inhibitions were responsible for blocking invasion through cell mediated and non-cell mediated pathways. In conclusion, disulfiram inhibited expression of MMP-2 and MMP-9, and regulated the invasion of U2OS, Caki-1 and Caski. These observations raise the possibility of clinical therapeutic applications for disulfiram used as a potential inhibitor of cancer invasion.

키워드

참고문헌

  1. A. F. Chambers and L. M. Matrisian. 1997. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89, 1260-1270 https://doi.org/10.1093/jnci/89.17.1260
  2. D. Cen, R. I. Gonzalez, J. A. Buckmeier, R. S. Kahlon, N. B. Tohidian and F. L. Meyskens, Jr. 2002. Disulfiram induces apoptosis in human melanoma cells: a redox- related process. Mol. Cancer Ther. 1, 197-204
  3. D. E. Kleiner and W. G. Stetler-stevenson. 1999. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol. 43 Supl., S42-51 https://doi.org/10.1007/s002800051097
  4. E. C. Woodhouse, R. F. Chuaqui and L. A. Liotta. 1997. General mechanism of meastasis. Cancer 80, 1529-1537 https://doi.org/10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F
  5. E. T. Waas, R. M. Lomme, J. Degroot, T. Wobbes and T. Hendriks. 2002. Tissue levels of active matrix metalloproteinase- 2 and 9 in colorectal cancer. Br. J. Cancer 86, 1876-1883 https://doi.org/10.1038/sj.bjc.6600366
  6. F. Chen, P. Eriksson, G. K. Hansson, I. Herzfeld, M. Klein, L. O. Hansson and G. Valen. 2005. Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque. Int. J. Mol. Med. 15, 57-65
  7. G. Y. Liu, N. Frank, H. Bartsch and J. K. Lin. 1998. Induction of apoptosis by Thiuramdisulfides, the reactive metabolites of dithiocarbamates, through coordinative modulation of NF-kB, c-fos/c-Jun, and p53 proteins. Mol. Carcinog. 22, 235-246 https://doi.org/10.1002/(SICI)1098-2744(199808)22:4<235::AID-MC5>3.0.CO;2-I
  8. H. Lovborg, F. Oberg, L. Rickardson, J. Gullbo, P. Nygren and R. Larsson. 2006. Inhibition of proteasome activity, nuclear factor-kappaB translocation and cell survival by the antialcoholism drug disulfiram. Int. J. Cancer 118, 1577-1580 https://doi.org/10.1002/ijc.21534
  9. H. Nagase and J. F. Woessner, Jr. 1999. Matrix metallproteinases, J. Biol. Chem. 274, 21491-21494 https://doi.org/10.1074/jbc.274.31.21491
  10. S. H Hong, K. K. Park, M. Junji, A. Kunio, T. S. Lee, T. K. Kwon, J. Y. Kwak, C. H. Kim and Y. C. Chang. 2005. Ascochlorin Inhibits Matrix Metalloproteinase-9 Expression by Suppressing Activator Protein-1-mediated Gene Expression through the ERK1/2 Signaling pathway. J. Biol. Chem. 280, 25202-25209 https://doi.org/10.1074/jbc.M413985200
  11. H. Sato and M. Seiki. 1993. Regulatory mechanism of 92kDa typeIVcollagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8, 395-405
  12. H. Sato, T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto and M. Seiki. 1994. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370, 61-65 https://doi.org/10.1038/370061a0
  13. I. Hininger, R. Waters, M. Osman, C. Garrel, K. Fernoholz, A. M. Roussel and R. A. Anderson. 2005. Acute prooxidant effects of vitamin C in EDTA chelation therapy and long-term antioxidant benefits of therapy. Free Radic. Biol. Med. 38, 1565-70 https://doi.org/10.1016/j.freeradbiomed.2005.02.016
  14. K. I. Matsumoto, S. Abiko and H. Ariga. 2005. Transcription regulatory complex including YB-1 controls expression of mouse matrix metalloproteinase-2 gene in NIH3T3 cells. Biol. Pharm. Bull. 28, 1500-1504 https://doi.org/10.1248/bpb.28.1500
  15. L. H. Wei, K. P. Lai, C. A. Chen, C. H. Cheng, Y. J. Huang, C. H. Chou, M. L. Kuo and c. Y. Hsieh. 2005. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through down regulation of nuclear factor kB. Oncogene 24, 390-398 https://doi.org/10.1038/sj.onc.1208192
  16. M. Marikovsky, N. Nevo, E. Vadai and C. H. Cerruti. 2002. Cu/Zn superoxide dismutase plays important role in angiogenesis. Int. J. Cancer 97, 34-41 https://doi.org/10.1002/ijc.1565
  17. M. Marikovsky, V. Ziv, N. Nevo, C. H. Cerruti and O. Mahler, 2003. Cu/Zn superoxide dismutase plays important role in immune response. J. Immunol. 170, 2993-3001 https://doi.org/10.4049/jimmunol.170.6.2993
  18. M. Takahashi, N. Oka, T. Naroda, M. A. Nishitani, K. Kanda, H. O. Kanayama and S. Kagawa. 2002. Prognostic significance of matrix metalloproteinases-2 activation ratio in renal cell carcinoma. Int. J. Urology 9, 531-538 https://doi.org/10.1046/j.1442-2042.2002.00516.x
  19. N. B. Mcdonnell, R. N. D. Guzman, W. G. Rice, J. A. Turpin and M. F. Summers. 1997. Zinc ejection as a new rationale for the use of cystamine and related disulfide containing antiviral agents in the treatment of AIDS. J. Med. Chem. 40, 1969-1976 https://doi.org/10.1021/jm970147+
  20. Park, J. H., Chung, J. J., Min, H. Y., Park, E. J., Hong, J. Y., Kim, W. B., Kim. S. H. and Lee, S. K. 2005. Inhibitory effect of DA-125, a new anthracyclineanalog anti-tumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases. Biochem. Pharmacol. 19, 21-31
  21. P. K. Vayalil, A. Mital and S. K. Katiyar. 2004. Proanthocyanidins from grape seed inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NF-kB. Carcinogenesis 25, 987-995 https://doi.org/10.1093/carcin/bgh095
  22. P. P. H. Lee, J. J. Hwang, G. Murphy and M. M. IP. 2000. Functional significance of MMP-9 in tumor necrosis factor- induced proliferation and branching morphogenesis of mammary epithelial cells. Endocrinology 141, 3764-3773 https://doi.org/10.1210/en.141.10.3764
  23. S. C. Huang, C. T. Ho, S. Y. L. Shiau and J. K. Lin. 2005. Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappaB and c-Jun. Biochemical Pharmacology 69, 221-232 https://doi.org/10.1016/j.bcp.2004.09.019
  24. S. G. Shiah, Y. R. Kao, F. Y. H. Wu and C. W. Wu. 2003. Inhibition of invasion and angiogenesis by zinc-chelating agent Disulfiram. Molecular Pharmacology 64, 1076-1084
  25. S. S. Brar, C. Grigg, K. S. Wilson, W. D. Holder, Jr., D. Dreau, C. Austin, M. Foster, A. J. Ghio, A. R. Whorton, G. W. Wtowell, L. B. Whittall, R. R. Whittle, D. . White and T. P. Kennedy. 2004. Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal- dependent manner in vitro, in mice and in a patient with metastatic disease. Mol. Cancer Ther. 3, 1049-1060
  26. W, J. H., Kim, Y. H., Baek, W. K., Suh, S. I., Suh, M. H., Park, J. W. and Kwon, T. K. 2003. Expressional regulation of cancer metastasis related gene, MMP-9, by Resveratrol. Journal of Bacteriology and Virology 33 235-243
  27. W. Wang, H. L. Mcleod and J. Cassidy. 2003. Disulfirammediated inhibition of NF-kB activity enhances cytotoxicity of 5-fluorouracil in colorectal cancer cell lines. Int. J. Cancer 104, 504-511 https://doi.org/10.1002/ijc.10972
  28. X. Wu, N. H. Bishopric, D. J. Discher, B. J. Murphy and K. A. Webster. 1996. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol. Cell. Biol. 16, 1035-1046 https://doi.org/10.1128/MCB.16.3.1035
  29. Y. Soini, J. Satta, M. Maatta and H. A. Harmainen. 2001. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. Journal of Pathology 194, 225-231 https://doi.org/10.1002/path.850
  30. Z. E. Sauna, Shukla S. and Ambudkar. S. V. 2005. Disulfiram, an old drug with new potential therapeutic uses for human cancers and fungal infections. Mol. Biosyst. 1, 127-134 https://doi.org/10.1039/b504392a

피인용 문헌

  1. Inorganic sulfur reduces the motility and invasion of MDA-MB-231 human breast cancer cells vol.5, pp.5, 2011, https://doi.org/10.4162/nrp.2011.5.5.375